Phlexglobal, a global provider of Trial Master File (TMF) technology and services for the global life sciences industry, has acquired Net Solutions Europe (NSE), a U.K.-based technology company delivering software solutions.

Phlexglobal has been working in partnership with NSE since 2010 on the development of PhlexEview; its market leading electronic TMF (eTMF) cloud based platform. The acquisition fortifies its position at the forefront of the provision of eTMF solutions and technology enabled services.

Peter McNaney, Phlexglobal chief technology officer, said, “As Phlexglobal’s technology partner, NSE has demonstrated a regulatory understanding of the sensitivity of the clinical documents we handle, and their expertise and experience is second to none. We also have appointed an expert eTMF product manager working as part of the newly expanded technology team, and this appointment coupled with the NSE acquisition will further ensure we are at the leading edge of eTMF technology capabilities.”

Rick Riegel, chief executive officer said, “This acquisition allows us to fast-track the future development of PhlexEview, our cloud based eTMF platform. The resulting enhanced capabilities will provide significant additional benefits to both our software and our services clients.”

Phlexglobal is committed to developing technology solutions for the TMF market to expedite study start up, facilitate regulatory inspection readiness, and improve management and oversight. The technology of choice for over 30 global companies, ranging from top 10 Pharma to biotech and CROs with thousands of worldwide users, a major new release of PhlexEview is anticipated later this year.